GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | 8/7/2026 5:18:45 PM | View | Proxy | SEC | Y 2025 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 5/15/2026 4:45:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $56,354,901 | EPS -$0.12 | ||
| Pasithea Therapeutics Corp. (KTTA) | 3/30/2026 5:45:31 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $60,240,070 | EPS -$2.91 | ||
| Pasithea Therapeutics Corp. (KTTA) | 12/29/2025 5:02:28 PM | View | Proxy | SEC | Y 2024 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 11/13/2025 5:16:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $13,630,664 | EPS -$0.41 | ||
| Pasithea Therapeutics Corp. (KTTA) | 8/14/2025 3:54:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $17,009,142 | EPS -$0.66 | ||
| Pasithea Therapeutics Corp. (KTTA) | 7/24/2025 4:16:26 PM | View | Proxy | SEC | Y 2024 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 5/15/2025 4:44:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $14,658,982 | EPS -$1.61 | ||
| Pasithea Therapeutics Corp. (KTTA) | 3/24/2025 5:04:35 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $16,064,719 | EPS -$12.69 | ||
| Pasithea Therapeutics Corp. (KTTA) | 11/13/2024 4:42:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $18,637,434 | EPS -$2.87 | ||
| Pasithea Therapeutics Corp. (KTTA) | 8/13/2024 4:49:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $17,663,384 | |||
| Pasithea Therapeutics Corp. (KTTA) | 5/28/2024 9:01:21 AM | View | Proxy | SEC | Y 2023 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 5/14/2024 4:48:33 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $22,408,099 | |||
| Pasithea Therapeutics Corp. (KTTA) | 3/29/2024 6:15:32 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $26,116,858 | EPS -$0.42 | ||
| Pasithea Therapeutics Corp. (KTTA) | 11/13/2023 4:58:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $30,657,411 | |||
| Pasithea Therapeutics Corp. (KTTA) | 10/26/2023 5:02:01 PM | View | Proxy | SEC | Y 2022 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 8/11/2023 5:17:08 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $38,149,391 | EPS -$0.01 | ||
| Pasithea Therapeutics Corp. (KTTA) | 5/12/2023 4:43:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $42,044,897 | EPS -$0.01 | ||
| Pasithea Therapeutics Corp. (KTTA) | 4/4/2023 4:38:41 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $486,559 +3,130.4% | Assets $45,180,089 | EPS -$0.53 | |
| Pasithea Therapeutics Corp. (KTTA) | 3/30/2023 5:38:02 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $486,559 +3,130.4% | Assets $45,180,089 | EPS -$0.53 | |
| Pasithea Therapeutics Corp. (KTTA) | 11/17/2022 4:54:35 PM | View | Proxy | SEC | Y 2021 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 11/15/2022 4:33:43 PM | View | Proxy | SEC | Y 2021 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 11/14/2022 4:48:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $218,608 | Assets $49,608,304 | EPS -$0.17 | |
| Pasithea Therapeutics Corp. (KTTA) | 8/15/2022 4:57:04 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $13,581 | Assets $53,027,687 | EPS -$0.11 | |
| Pasithea Therapeutics Corp. (KTTA) | 7/28/2022 10:09:39 AM | View | Proxy | SEC | Y 2021 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 7/14/2022 12:03:26 PM | View | Proxy | SEC | Y 2021 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 5/16/2022 4:50:22 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $13,658 | Assets $51,078,565 | ||
| Pasithea Therapeutics Corp. (KTTA) | 5/13/2022 12:46:51 PM | View | Proxy | SEC | Y 2021 | ||||||
| Pasithea Therapeutics Corp. (KTTA) | 5/12/2022 4:28:19 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | ||||
| Pasithea Therapeutics Corp. (KTTA) | 3/30/2022 4:26:41 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | ||||
| Pasithea Therapeutics Corp. (KTTA) | 3/30/2022 4:17:34 PM | View | Financials | Earnings | WIRE | Y 2021 | Rev $15,062 | Assets $53,320,581 | EPS $0.12 | Export Earnings Model | |
| Pasithea Therapeutics Corp. (KTTA) | 11/18/2021 5:14:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $21,042,416 | EPS -$0.17 |